NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 7 Jul · 12:06 IST

Neuland Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Neuland Laboratories has submitted a routine quarterly certificate to the stock exchanges as required under SEBI's Depositories Regulations. The certificate was issued by its Registrar and Share Transfer Agent, KFin Technologies Limited, for the quarter ended June 30, 2025. It confirms that details of all securities dematerialized and rematerialized during the quarter have been reported to both NSDL and CDSL, as well as to the stock exchanges where the company is listed (BSE and NSE). This is a standard compliance filing with no business or financial numbers disclosed.

Likely market impact

No impact on shareholders or stock price — this is a routine regulatory compliance submission confirming that share demat/remat activity has been properly reported to the depositories and exchanges.